Enz, Albert
Novartis (Switzerland) · Novartis Institutes for BioMedical Research
3 papers on CoChat
Most cited papers
- Verified
Targeting acetylcholinesterase and butyrylcholinesterase in dementia
Lane, R. M., Potkin, S. G., & Enz, A. (2005) · The International Journal of Neuropsychopharmacology
Cholinesterase and Neurodegenerative DiseasesAlzheimer's disease research and treatments
Cited by 654
- Verified
Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis
Boncristiano, S., Calhoun, M. E., Kelly, P. H., Pfeifer, M., Bondolfi, L., Stalder, M., Phinney, A. L., Abramowski, D., Sturchler-Pierrat, C., Enz, A., et al. (2002) · The Journal of Neuroscience
Alzheimer's disease research and treatmentsCholinesterase and Neurodegenerative Diseases
Cited by 160
- Verified
AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: Identification, SAR and pharmacological characterization
Vranesic, I., Ofner, S., Flor, P. J., Bilbe, G., Bouhelal, R., Enz, A., Desrayaud, S., McAllister, K., Kuhn, R., & Gasparini, F. (2014) · Bioorganic & Medicinal Chemistry
Neuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling
Cited by 59
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free